Catalyst Wire Dossier Catalyst Wire Dossier

Polivy

polatuzumab vedotin · Genentech (Roche)
Drug timelines are a Plus or Pro feature.

25 regulatory and trial events tracked for Polivy, covering 2019-06-10 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma [Phase 1]

See pricing